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Abstract
Mutations in cyclin-dependent kinase-like 5 (CDKL5) cause early-onset epileptic encephalopathy, a neurodevelopmental
disorder with similarities to Rett Syndrome. Here we describe the physiological, molecular, and behavioral phenotyping of a
Cdkl5 conditional knockout mouse model of CDKL5 disorder. Behavioral analysis of constitutive Cdkl5 knockout mice
revealed key features of the human disorder, including limb clasping, hypoactivity, and abnormal eye tracking. Anatomical,
physiological, and molecular analysis of the knockout uncovered potential pathological substrates of the disorder, including
reduced dendritic arborization of cortical neurons, abnormal electroencephalograph (EEG) responses to convulsant
treatment, decreased visual evoked responses (VEPs), and alterations in the Akt/rpS6 signaling pathway. Selective knockout
of Cdkl5 in excitatory and inhibitory forebrain neurons allowed us to map the behavioral features of the disorder to
separable cell-types. These findings identify physiological and molecular deficits in specific forebrain neuron populations as
possible pathological substrates in CDKL5 disorder.
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Introduction
Mutations in the X-linked cyclin-dependent kinase-like 5
(CDKL5) gene cause early-onset epileptic encephalopathy [1].
Although CDKL5 disorder shares several features with Rett
Syndrome, a neurodevelopmental disorder caused by mutations in
the X-linked MECP2 gene [2], recent work assessing data from 86
subjects has argued that it should be considered a distinct clinical
entity, primarily due to its early onset and lack of clinical
regression following a period of normal development [3]. The
primary clinical features of CDKL5 disorder are seizures initiating
in the first few months of life, stereotypical hand movements,
motor rigidity, and deficient language acquisition [3,4]. Several
additional features have been noted in some carriers, including
gastrointestinal problems, bruxism [4,5], and a characteristic
sideways glance [4]. The disorder is most frequently associated
with nonsense or putative detrimental missense mutations and is
thought to be caused by a loss of CDKL5 function, although no
clear relationship between the type or location of mutations and
symptom severity has been reported [6]. The disorder is more
frequently reported in females (8:1) [3], probably due to the more
severe consequences of dominant X-linked mutations in males
than in females. CDKL5 mRNA is expressed in brain, testes, and
thymus [7,8] and the protein product is found in both the
cytoplasm and nucleus, where it colocalizes with nuclear speckles
[9,10]. The mouse Cdkl5 gene expresses two isoforms, with
expression segregated to neurons and astrocytes [11]. Data
demonstrate that CDKL5 can bind to and phosphorylate MECP2
in vitro, suggesting a possible molecular link between CDKL5
disorder and Rett Syndrome [8].
Here we generated and characterized mice carrying a targeted
conditional knockout allele of Cdkl5. Behavioral characterization
was carried out to identify features that mimic the clinical features
described in CDKL5 disorder, including seizures, motor behavior,
and eye tracking. Several physiological substrates were examined,
including spontaneous and convulsant-induced electroencephalo-
graph (EEG) activity and visual evoked potentials (VEPs).
Anatomical analysis was aimed at identifying aberrant morpho-
logical features of neurons, including cortical neuron dendritic
arborization, reported following the developmental knockdown of
Cdkl5 in rat [11], in Mecp2 knockout mice [12–14], and in
postmortem samples from MECP2 carriers [15]. Molecular
analyses were carried out on several signaling pathways identified
to be altered inMecp2 knockout mice and thought to be relevant to
Rett Syndrome. Finally, we used a conditional knockout approach
to map the behavioral features identified to distinct populations of
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forebrain neurons. Our findings disclose a series of behavioral
phenotypes homologous to those described in CDKL5 disorder
and demonstrate the underlying neuronal cell-types and brain
regions. In addition, our data reveal common deficits in a specific
signaling pathway in Cdkl5 and Mecp2 knockout mouse models,
suggesting potentially overlapping molecular deficits in CDKL5
disorder and Rett Syndrome.
Methods
Ethics statements
All procedures were approved by The Institutional Animal Care
and Use Committee (IACUC) of The European Molecular
Biology Laboratory (EMBL) and were conducted according to
the Italian Ministry of Health and commensurate with NIH
guidelines for the ethical treatment of animals (NIH publication
No. 85-23, revised 2011). All surgery was performed under
anesthesia with tribromoethanol 250 mg/Kg (avertin). After
anesthesia, for fresh brains collections mice were sacrificed by
cervical dislocation while for fixed tissues collections mice were
perfused transcardially with 4% paraformaldehyde. All efforts
were made to minimize suffering.
Mouse strains and husbandry
All mice were handled according to protocols approved by the
Italian Ministry of Health and commensurate with NIH guidelines
for the ethical treatment of animals. Mice for testing were
produced by crossing Cdkl5KO/+ females with Cdkl5KO/Y males
and Cdkl5KO/X females with +/Y male. Littermate controls were
used for all experiments. A portion of the behavioral data derived
from knockout mice containing the neomycin selection cassette.
No difference in behavior was noted between this allele and the
neo-negative allele and the results were combined. For dendritic
reconstructions mice with sparse fluorescent labeling of cortical
neurons were obtained by crossing Thy1::GFP/Thy1::GFP;+/Y
males with +/+;Cdkl5KO/X females and Thy1::GFP/+;Cdkl5KO/Y
males with +/+;Cdkl5KO/X females. After weaning, mice were
housed three to five per cage on a 12 h light/dark cycle (lights off
at 19:00 h) in a temperature-controlled environment (2162 C)
with food and water provided ad libitum. For tissues collections all
surgery was performed under anesthesia with tribromoethanol
250 mg/Kg (avertin). All efforts were made to minimize suffering.
Generation of Cdkl5 knockout mice
A 10 kb genomic fragment containing exon 4 of Cdkl5
(ENSMUSE00000346596) was subcloned into a pDTA targeting
plasmid by recombineering-mediated transfer from a 178-kb
genomic fragment containing the C57BL/6J mouse Cdkl5 locus
(RP23-213O8, ChoriBACPAC, Oklahoma, CA). A loxP site was
inserted 806 bp upstream of the exon by recombineering-
mediated insertion of a loxP-flanked pEM7::kanamycin gene
and subsequent Cre recombination. An FRT-flanked pEM7/
PGK::neomycin selection cassette was inserted 347 bp down-
stream of exon 4. The plasmid was linearized with NruI before
electroporation into ES cells (129/Sv6C57BL/6N, clone A8, gift
of A. Wutz, Wellcome Trust Centre for Stem Cell Research, Stem
Cell Institute, University of Cambridge). G418-resistent clones
were identified and screened by long-range PCR. Hybridization
with a specific probe for the 59 and 39 arms was used to confirm
PCR results. Two independent positive ES cell clones were
injected into C57BL/6N host embryos using a piezo-drill assisted
8-cell stage injection procedure developed at EMBL. Four out of
five offspring (all .95% ES cell derived) provided germline
transmission. Positive offspring were crossed to C57BL/6J
congenic FLP-deleter mice [16] to remove the neomycin selection
cassette and further crossed to C57BL/6J congenic Cre-deleter
mice [17] to generate the Cdkl5 null allele.
Immunofluorescence, dendritic reconstruction
Mice were anesthetized (Avertin, Sigma-Aldrich, St. Louis,
MO) and perfused transcardially with 4% paraformaldehyde at 2
months of life. Brains were removed from the skull and post-fixed
overnight at 4 C. Coronal sections (60 and 250 mm for
immunofluorescence and neuronal reconstruction, respectively)
were cut on a vibratome (Leica Microsystems, Mannheim,
Germany) in 0.1 M phosphate buffer. For immunofluorescence
brain sections were washed in phosphate-buffered saline 0.5%
Triton-X and transferred in a 15 mM sodium citrate solution,
pH 8.0 for 30 min at 80 C, then washed in phosphate-buffered
saline with 0.5% Triton-X and blocked with blocking buffer (2%
BSA in phosphate-buffered saline, 100 mm glycine, 1% Triton-X),
incubated with primary antibodies overnight at 4 C (rabbit anti-
Cdkl5, 1:250, Sigma-Aldrich; mouse anti-SC35, 1:20, rabbit anti-
MeCP2, 1:1000, Cell Signaling, Danvers, MA), incubated with an
appropriate Alexa Fluor secondary antibody (1 h at room
temperature), stained with DAPI, and mounted in Moviol
(Calbiochem, Nottingham, UK). Images were acquired on a
confocal microscope (TCS SP5 AOBS, Leica Microsystems). For
neuronal reconstruction, brain sections were washed in phosphate-
buffered saline, stained with DAPI, and mounted in Moviol
(Calbiochem). Total dendritic length and Sholl analysis was
measured using ImageJ software from confocal images.
Anatomical measurements
Mice were anesthetized (Avertin, Sigma-Aldrich) and perfused
transcardially with 4% paraformaldehyde at 2 months of life.
Brains were removed from the skull and post-fixed overnight at
4uC. The right hemisphere was dehydrated through a series of
ascending ethanol concentrations, embedded in paraffin, and cut
with a microtome (8 mm) and mounted on poly-lysine slides. One
of 20 sections from the dentate gyrus was stained with toluidine
blue according to the Nissl method. Bright field images (Leitz
Diaplan, Wetzlar, Germany) were acquired with a Coolsnap-Pro
digital camera (Media Cybernetics, Silver Spring, MD) and
anatomical measurements carried out with Image Pro Plus
software (Media Cybernetics).
Immunohistochemistry
Animals were anesthetized with chloral hydrate and transcar-
dially perfused with ice cold 4% paraformaldehyde in 0.1 M
phosphate buffer (PB, pH 7.4). After perfusion, the brains were
dissected and kept in the same fixative solution overnight at 4 C.
After several washes in 0.1 M PB, brains were cryoprotected by
immersion in 10%, 20%, and 30% sucrose solutions. One brain
hemisphere was cut in 30 mm sections with a cryostat, collected in
phosphate buffered saline and processed for free-floating immu-
nohistochemistry as described [18]. After a blocking step in PBS,
10% NGS, 0.05% Triton X-100 sections were incubated
overnight at room temperature with the following primary
antibodies: rabbit anti-phospho-rpS6 (235/236) XP (1:200); rabbit
anti-phospho-rpS6 (240/244) XP (1:800); rabbit anti-rpS6 (1:100;
Cell Signaling Technology) diluted in PBS, 3% NGS, 0.05%
Triton X-100. Sections were washed in PBS, incubated for 1 hour
with goat anti-rabbit biotinylated secondary antibodies (1:250;
Vector Labs, Burlingame, CA) and transferred to a solution
containing a biotin-avidin complex (1:100,Vector Labs). The
peroxidase reaction product was visualized by incubation in a
solution containing 3,39-diaminobenzidine (0.05% DAB in Tris-
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HCI, pH 7.6) with 0.01% H2O2 for 3 min. Sections were
mounted on gelatin-coated glass slides and observed with a light
microscope (Eclipse 800, Nikon, Tokyo, Japan) equipped with a
CCD camera (Axiocam HRc, Zeiss, Jena, Germany). Quantita-
tion of immunolabeling experiments was carried out from optical
density (OD) measurements on 106micrographs using ImageJ by
an operator blind to genotype. Measurements of OD in cortex
were obtained from 100650 mm measuring boxes that were
randomly placed in each cortical layer. Histograms illustrate the
average OD obtained from three repeated measures in 4–5
sections per experimental animal. The mean OD of the corpus
callosum was subtracted as background staining.
Western blotting
Mice at 2 months of life were decapitated and brains rapidly
collected on ice and frozen in liquid nitrogen. One hemisphere
was homogenized in lysis buffer (50 mM HEPES pH 7.0,
250 mM NaCl, 0.5% NP-40, 5 mM EDTA, 1 mM DTT) using
an automated dounce. A protease/phosphatase inhibitor mix
composed of 0.5 mM Na3VO4, 0.5 mM PMSF, protease inhibitor
mixture (Roche Applied Sciences, Monza, Italy), and 50 mM NaF
was added to all buffers. Homogenates were mixed for 20 min at 4
C and centrifuged 20 min at 4 C at maximum speed. Supernatant
was collected and stored at 280 C. The protein content was
determined by bicinchoninic acid assay (Pierce, Rockford, IL). For
the preparation of hippocampal extracts from P19 mice, tissues
were homogenized in RIPA buffer (Tris-HCl, 50 m M, NaCl
150 mM. Triton X-100 1%, SDS, 0,1%, sodium deoxycholate
0,5%, PMSF 1 mM, protease and phosphatase inhibitors cocktail,
1% (Sigma)). Proteins were separated by SDS-PAGE, transferred
to nitrocellulose membranes, blocked in 5% milk, TBS, 0.1%
Tween, and incubated with rabbit anti-CDKL5 1:250 (Sigma-
Aldrich), mouse anti-Cdkl5 1:250 (see below), and rabbit anti-
MECP2 (1:1000), anti-AKT (1:1000), anti-p-AKT (1:1000), anti-
BDNF (1:200; Santa Cruz Biotechnology, Santa Cruz, CA) and
anti-tubulin (1:5000; Sigma-Aldrich) overnight at 4 C, incubated
with secondary antibodies (1 h at room temperature), developed
using ECL detection (GE Healthcare, Chalfont St. Giles, UK),
and images acquired and quantified using a digital camera
(ChemiDoc XRS+ System, BioRad, Hercules, CA).
Semi-quantitative and quantitative PCR
Brains were collected from mice at 2 months, washed in PBS-
DEPC and rapidly frozen in liquid nitrogen. One hemisphere was
homogenized using an automated dounce and total RNA
extracted (RNeasy Mini Kit, Qiagen, Hilden, Germany) and
converted into first-strand cDNA (SuperScript II Reverse Tran-
scriptase, Invitrogen, Paisley, UK) using oligo-dT according to the
manufacturer’s protocol. For semi-quantitative PCR, DNA was
amplified using primers against Cdkl5 exons using 16PCR Buffer
(Promega, Madison, WI), 0.5 units of Dream Taq (Promega) and
200 mM each dNTPs (Fermentas, Vilnius, Lithuania). For
SYBER green qPCR (Finnzymes, Vantaa, Finland) exons were
amplified using primers against exons 2–3 and 9–10 and control
primers against Abl.
EEG analysis
Male mice (2–4 months) were anesthetized with ketamine/
xylazine supplemented with isofluorane as needed, kept on a
heating pad to maintain body temperature at 3561 C, and
immobilized in a stereotaxic frame. An incision above the skull was
cut and burr holes drilled into the skull. Four stainless steel screws
were used as electrodes placed bilaterally above hippocampus
(2.0 mm posterior, 1.5 mm lateral to bregma) and frontal cortex
(1.8 mm anterior, 1.5 lateral to bregma). Ground and reference
screws were anchored on the posterior and middle portions of the
skull, respectively. A wireless Neurologger 2A recording device
(400 HZ sampling rate) acquired and stored data in real-time for
later downloading [19]. After surgery animals were housed
individually and allowed at least 1 week to recover. Mice were
tested in a novel cage for a 30 min baseline period followed by a
2 hour recording after treatment with kainic acid (10 mg/kg and
25 mg/kg, i.p.). Each animal received both doses separated by at
least one day. Data were downsampled to 200 Hz and filtered
between 1–25 Hz (Chebyshev I filter, 3rd order). To quantify
seizure episodes, a Fourier transform (4 s window, 3.5 s overlap,
2 hours period) was applied to the EEG. Seizure events in the 1–
8 Hz frequency range were used to quantify amplitude. The
baseline period was used as a cutoff criterion (mean power+8x SD)
to define seizure events.
Behavior testing
Clasping. Mice were suspended by their tail for 2 min and
hind-limb clasping was assessed from video recordings. Clasping
was defined as present if it occurred for more than 5 seconds in an
animal.
Home-cage activity. Locomotion was measured using activ-
ity-monitoring cages similar in size, shape, and material to the
home cage (TSE Systems, Bad Homburg, Germany). A mouse was
placed in the chamber at least 3 h before recording started.
Relative activity was monitored continuously for four days and
binned into 12 h epochs.
Open field. Mice were placed in the center of a 50650 cm
open arena equipped with video tracking and infrared rearing
detection systems (VideoMot2, TSE Systems). Cumulative dis-
tance travelled was collected in 5 min intervals for 30 min.
Visual drum. Mice were placed on a 12 cm diameter
platform within a 28 cm visual-tracking drum (L&H Creations,
Baldenheim, France). The opto-kinetic response (head tracking)
was assessed from video recordings. Each mouse was tested using
vertical stripes (6 mm and 15 mm width) at two speeds (2 rpm and
4 rpm) and data were averages as genotype effects were similar
across conditions.
VEPs. Animals were anesthetized with urethane (0.7 ml/kg
i.p.; 20% in saline; Sigma-Aldrich) and placed in a stereotaxic
frame with full viewing of the visual stimulus. Additional doses of
urethane were used, if necessary, to keep the anesthesia level stable
throughout the experiment. Body temperature was monitored
with a rectal probe and maintained at 37.0 C with a heating pad.
A hole was drilled bilaterally in the skull, overlying the binocular
portion of the primary visual cortex (binocular area Oc1B). After
exposure of the brain surface, the dura was removed. A glass
micropipette (4 mm tip, 3 M NaCl) was inserted perpendicularly to
the stereotaxis plane into the cortex contralateral to the measured
eye. In most experiments, microelectrodes were inserted 3.1–
3.3 mm lateral to the intersection between sagittal- and lambdoid-
sutures and advanced 100 mm within the cortex. Electrical signals
were amplified (5,000–20,000 fold), bandpass filtered (0.3–
100 Hz), and averaged (at least 50 blocks of 2 events each) in
synchrony with the stimulus contrast reversal. Transient VEPs in
response to abrupt contrast reversal (1 Hz) were evaluated by
measuring the peak-to-baseline amplitude and peak latency of the
major component. VEPs in response to a blank stimulus were also
frequently recorded to estimate of noise. Visual stimuli were
horizontal sinusoidal gratings of different spatial frequency and
contrast generated by a VSG2/2 card (Cambridge Research
System, Cheshire, UK) and presented on a computer display
(25 cm distance, mean luminance = 25 cd/m2). VEP amplitude
A Mouse Model of CDKL5 Disorder
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decreases with increasing stimulus spatial frequency; visual acuity
was obtained by extrapolation to zero amplitude of the linear
regression through the last four to five data points in a curve where
VEP amplitude is plotted against log spatial frequency [20].
Monoclonal antibody production
Portions of the Cdkl5 cDNA encoding amino acids 13–297 and
766–938 were cloned in the N-terminal His6-tag SUMO3 vector
for expression in bacteria followed by His-tag purification and
SenP2 cleavage. About 10 mg of purified protein was injected into
CD-1 mice to raise antibodies. Seven injections were necessary to
obtain a high titer antigen-response as tested by ELISA. Spleen
was taken from the immunized mouse and the splenocytes were
fused to Mouse myeloma cell-line Sp2 using polyethylene glycol.
Fused cells were plated into twenty 96 well plates, with
approximately one cell/well. The resulting hybridoma clones
were tested for reactivity by antigen microarray against the
immobilized original antigens [21]. Six and seven hybridomas
were positive for the N-terminal and C-terminal antigens,
respectively, and 1/6 and 2/7 clones showed a band of the
expected size on Western blots using brain extracts from wild-type
mice that were absent from knockout mice. A single clone for each
antigen was submitted for large scale IgG purification (InVivo
BioTech Services, Hennigsdorf, Germany). The antibody raised
against the C-terminal of Cdkl5 was used in the present work.
Statistical Analysis
Data were analyzed using Student’s t-test (for male genotype) as
well as one-or two-way ANOVA (for female genotype) using Prism
software (GraphPad, La Jolla, CA; a=0.05). Post hoc comparisons
were analyzed by two-tailed paired and unpaired t-tests. Dendrite
length was analyzed using the Kolmogorov-Smirnov (K-S) fitting
test, and then paired comparisons. For immunohistochemistry,
data were statistically analyzed by Student’s t-test and one or two-
way ANOVA using Prism software (GraphPad). For the open
field, data were analyzed in 5 min increments using a two-way
ANOVA with repeated measures
Results
Construction and validation of Cdkl5 conditional
knockout mice
A constitutive knockout allele of Cdkl5 was produced by
germline deletion of exon 4 of a Cdkl5 conditional knockout allele
produced by standard gene targeting in embryonic stem cells
(Figure S1A). Western blot analysis of whole brain extracts
(Figure 1A) and immunofluorescence of brain sections
(Figure 1B) confirmed the absence of Cdkl5 protein in
hemizygous male and homozygous female knockout mice and
intermediate levels in heterozygous females. Absence of the full-
length protein in whole brain extracts of Cdkl5 knockout mice was
further confirmed by Western blot analysis with a monoclonal
antibody (EA7) raised against the C-terminus of mouse Cdkl5
Figure 1. Validation of Cdkl5 knockout mice. (A) Western blot analysis of whole brain protein extracts of wild-type (X/X), heterozygous (-/X), and
homozygous (-/-) female and wild-type (X/Y) and hemizygous (-/Y) male Cdkl5 knockout mice using polyclonal (top panel) and monoclonal (bottom
panel) anti-Cdkl5 antibodies. (B) Immunofluorescence analysis of CA1 hippocampus brain sections from adult male wild-type (WT) and Cdkl5
knockout (KO) mice using polyclonal anti-Cdkl5 antibody, showing staining of neuronal cell bodies and nuclear puncta (Scale bar 40 mm). (C) Anti-
Cdkl5, SC35 and Mecp2 immunofluorescence analysis of S1 cortex brain sections from adult male wild-type (WT) mice. Arrowheads point to regions
of co-localization between CDKL5 and SC35 and Mecp2 and SC32 (Scale bar 10 mm).
doi:10.1371/journal.pone.0091613.g001
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(Figure 1A). Immunofluorescence confirmed the localization of
Cdkl5 protein to both cytoplasm and nucleus of neurons
(Figure 1BC and Figure S1F) with co-localization in the
nucleus with the nuclear speckle marker SC35, as previously
reported in cultured cells [10]. Notably, cytoplasmic staining was
more prominent in hippocampal than in cortical pyramidal
neurons suggesting a cell-type specific regulation of nuclear
translocation (Figure 1BC). Immunoreactivity was seen in
astrocytes, but not microglia as identified by their homogeneous
and compact DAPI staining, respectively. On the other hand,
nuclear Mecp2 immunoreactivity did not co-localize with SC35,
but rather mirrored the pattern of heterochromatin revealed by
DAPI staining (Figure 1C). These data confirm the distinct
nuclear localization of Cdkl5 and Mecp2 in brain and suggest that
they have at least partially non-overlapping functions there.
Behavioral deficits in Cdkl5 knockout mice
Hemizygous male and homozygous female Cdkl5 knockout mice
showed normal viability, body weight, and absolute as well as
relative brain weight (Figure S2AE). A general behavioral screen
[22] revealed abnormal clasping of hind-limbs in a significant
fraction of heterozygous and homozygous female as well as
hemizygous male Cdkl5 knockout mice while no, or very low levels
of clasping were seen in wild-type littermates (Figure 2AB).
Continuous monitoring of home cage activity showed a significant
decrease in locomotion in both homozygous female and hemizy-
gous male Cdkl5 knockouts and intermediate levels in heterozygous
Cdkl5 knockout females when compared to wild-type littermates
(Figure 2CD). However, hypolocomotion was not seen when
mice were placed in a novel open arena (Figure S2B) suggesting
that the deficit did not reflect a reduced capacity for locomotion.
Next, we measured head tracking responses to a continuously
moving visual stimulus in the visual drum test [23]. Hemizygous
Figure 2. Behavioral impairments in Cdkl5 knockout mice. (A–B) Percentage of mice showing hind-limb clasping was significantly increased in
adult female and male Cdkl5 knockout mice (X/X, N = 28; -/X, N = 38; -/-, N = 32; X/Y, N= 55; -/Y, N = 42). Home cage activity was significantly decreased
in adult (C) female and (D) male Cdkl5 knockout. (E) Number of eye tracking saccades was significantly decreased in adult female and male Cdkl5
knockout mice (X/X, N= 10; -/X, N= 9; -/-, N = 10; X/Y, N= 10; -/Y, N = 11). (F) Amplitude of the VEP short latency wave evoked by a low spatial
frequency grating (0.05 c/deg) was significantly reduced in adult female Cdkl5 knockouts (X/X, N= 5; -/X, N= 3; -/-, N = 6; *P,0.05, **P,0.01).
doi:10.1371/journal.pone.0091613.g002
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male Cdkl5 knockout mice showed a significant decrease in the
number of head tracks performed in the test compared to wild-
type littermates while homozygous female knockouts showed a
trend for reduced head tracking (Figure 2E). To determine
whether head tracking deficits might be a consequence of defects
in visual system function we quantified visual evoked potentials
(VEPs) [24] to estimate visual acuity. The amplitude, but not
latency, of the first positive wave (recording from V1 superficial
layers) was significantly reduced in both heterozygous and
homozygous knockout females when compared to wild-type
littermates (Figure 2F) indicating deficient visual processing in
the mutant mice.
Although early onset seizures are a prominent feature of
CDKL5 disorder, no evidence for spontaneous seizures emerged
during videotaped observations of adult Cdkl5 knockout mice
either in the home cage or following transfer to a novel cage.
Electroencephalographic (EEG) recordings from implanted sur-
face electrodes in freely behaving animals did not reveal
spontaneous epileptiform activity in hemizygous male Cdkl5
knockout mice (Figure 3AB). Pharmacological induction of
seizures with kainic acid was monitored by surface EEG. Low
dose kainic acid did not induce overt seizures, but caused
occasional epileptiform activity patterns in both hemizygous Cdkl5
male knockouts and wild-type littermates. At the higher dose,
kainic acid induced overt seizures, as evidenced by periods of
sudden immobility and in some cases tonic-clonic convultions in
both hemizygous Cdkl5 knockout and wild-type littermate mice.
Correspondingly, prominent epileptiform activity bursts were
observed in the EEG of both genotypes (Figure 3AB). Cdkl5
knockout mice did not differ from wild-type littermates in latency
to epileptiform activity bursts suggesting similar susceptibility to
the drug (Figure 3C). However, the mean duration of high-
amplitude bursts was longer and the frequency lower in Cdkl5
knockout compared to wild-type littermates (Figure 3DE). Power
spectrum analysis revealed a significant dose-dependent increase
in low frequency EEG power in wild-type, but not hemizygous
Cdkl5 male knockouts treated with kainic acid when compared to
baseline (Figure 3FG). To investigate whether genetic back-
Figure 3. Altered seizure response in Cdkl5 knockout mice. (A–B) Representative electroencephalogram (EEG) traces recorded from surface
electrodes placed over the somatosensory cortex in freely moving male wild-type (WT) and Cdkl5 knockout (KO) mice. (Left) Baseline EEG before drug
treatment. (Right) EEG taken during 2 hour post-injection period following treatment with high dose (25 mg/kg, i.p.) kainic acid. (expanded trace)
Detail of epileptiform event showing low frequency, high amplitude activity. (C) Latency to the first epileptiform event did not differ between wild-
type and Cdkl5 knockout mice, but (D) mean duration of events was longer and (E) mean frequency was lower in knockouts. Average EEG power
spectra of (left) baseline and (right) post-injection periods for (F) low dose (10 mg/kg, i.p.) and (G) high dose (25 mg/kg, i.p.) kainic acid treatment
revealed a significant, dose-dependent increased in low frequency EEG power in wild-type, but not Cdkl5 knockout mice (mean6 SEM; WT: N = 4, KO:
N = 5).
doi:10.1371/journal.pone.0091613.g003
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ground might alter the penetrance or expressivity of the Cdkl5
mutation on EEG activity, we backcrossed consitutive Cdkl5
knockout mice onto the DBA/2J background. Consistent with
previous reports [25], seizure susceptibility was signficantly
enhanced on this genetic background as evidenced by more
severe seizures with the same kainic acid dose (data not shown).
However, no evidence of spontaneous seizures emerged in the
knockout mice and kainic acid-induced epileptiform activity was
similar in wild-type and Cdkl5 knockout mice on this genetic
background (Figure S3) suggesting that the relative seizure
resistence of the founder background was not masking an epileptic
phenotype in the knockout. These data reveal that while Cdkl5
knockout mice do not exhibit spontaneous seizures or increased
seizure susceptibility, they do show abnormal EEG response to
pro-convulsant treatment.
Reduced dendritic arborization in Cdkl5 knockout mice
Dendritic arborization is significantly reduced in cortical
pyramidal neurons from both Rett Syndrome subjects [15,26,27]
as well as Mecp2 knockout mice [28,29]. It is not know if similar
deficits exist in the brains of subjects carrying CDKL5 mutations.
However, siRNA-mediated knockdown of Cdkl5 causes a reduc-
tion in dendritic arborization both in vitro and in vivo [11]. To
quantify dendritic arborization we crossed Cdkl5 knockout mice to
mice carrying the Thy1::GFP transgene [30] and reconstructed
individual layer 5 cortical (Figure 4A) and CA1 (Figure S4 G,H)
pyramidal neurons. Total length of apical dendritic arbors was
significantly reduced in homozygous female and hemizygous male
Cdkl5 knockout cortical and hippocampal pyramidal neurons
compared to wild-type littermates, while dendritic arbor length of
cortical neurons in heterozygous female Cdkl5 knockout mice
showed an intermediate mean distribution (Figure 4B and S4I).
Notably, dendritic arbor length in heterozygous female mice
showed a bimodal distribution (Kolmogorov-Smirnov test,
P = 1.2610214) consistent with a cell autonomous function of the
X-linked Cdkl5 gene in cells in which either one or the other X
chromosome has been inactivated. Reduced dendritic arborization
was associated with a significant reduction in cortical thickness in
both homozygous female and hemizygous male Cdkl5 knockout
mice when compared to wild-type littermates with intermediate
levels seen in heterozygous female knockouts (Figure 4C).
Significant reductions in the thickness of hippocampal layers were
found, including CA1 stratum oriens and the molecular layer of both
the upper and lower blades of the dentate gyrus (Figure S4B–F).
Sholl analysis of pyramidal neuron dendrites revealed significant
decreases in branching at 100–130 mm from the soma of cortical
pyramidal neurons and at 80–120 mm and 140–160 mm from the
soma of hippocampal pyramidal neurons in homozygous female
and hemizygous male Cdkl5 knockout mice compared to wild-type
littermates (Figure S5AB; P,0.05, Tukey test).
Signaling deficits in Cdkl5 knockout mice
Next, we examined whether expression of Mecp2 protein and
signaling factors known to be altered in Mecp2 knockout mice
might be similarly affected in Cdkl5 knockouts. Western blots on
whole brain extracts revealed no change in Mecp2 protein levels in
Cdkl5 knockout mice (Figure 5A and Figure S6A). Levels of
BDNF immunoreactivity, reported to be reduced in Mecp2
knockout brain [31–33], were unaltered in Cdkl5 knockout brain
(Figure 5A and Figure S6B). However, decreased levels of
phosphorylated Akt were observed in extracts of hippocampus
from Cdkl5 knockouts when compared to wild-type littermates
(Figure 5BC). Moreover, as reported in Mecp2 mutant mice [18],
levels of ribosomal protein S6 (rpS6) phosphorylated at position
240/244 were significantly reduced in somatosensory cortex of
homozygous and heterozygous female and hemizygous male Cdkl5
knockout mice when compared to wild-type littermates
(Figure 5DF). Levels of rpS6 phosphorylated at position 235/
236 showed a trend for reduction in mutants (Figure 5EG). An
analysis of individual cortical layers revealed reduced levels of
phospho-rpS6 (240/244) and phospho-rpS6 (235/236) across
layers 2–6 in both female and male mutant mice (Figure S7C–F).
Mapping of Cdkl5 behavioral phenotypes
To help identify the cell-types in which Cdkl5 deletion drives
pathological phenotypes, we examine mice carrying a Cre-
conditional knockout (cKO) allele of Cdkl5 (Figure S1A). For
deletion in forebrain GABAergic neurons (e.g. cortical interneu-
rons, striatal medium spiny neurons) we crossed the Cdkl5
conditional knockout allele with the Dlx5/6::Cre transgene [34].
For deletion in cortical glutamatergic neurons (e.g. cortical and
hippocampal pyramidal neurons) we crossed the Cdkl5 conditional
knockout allele with the Emx1::Cre transgene [35]. Both Dlx5/6
and Emx1 conditional knockout mice appeared outwardly normal
at birth and showed normal body weight and viability when
compared to littermate controls (Figure S8). A general behavioral
screen [22] revealed abnormal clasping of hind-limbs in a
significant fraction of heterozygous female as well as hemizygous
male Emx1-conditional, but not Dlx5/6-conditional Cdkl5 knock-
out mice when compared to control littermates (Figure 6AB).
Continuous monitoring of home cage activity revealed a
significant decrease in locomotion in hemizygous male Dlx5/6-
Figure 4. Abnormal dendritic branching in Cdkl5 knockout
mice. (A) Representative images of reconstructed neurons from adult
male wild-type (WT, top panel) and Cdkl5 knockout (KO, bottom panel)
mice. (B) Total dendrite length was significantly reduced in female and
male Cdkl5 knockout mice (X/X, N = 6; -/X, N= 15; -/-, N = 6; X/Y, N= 15;
-/Y, N= 15). Heterozygous female knockout mice showed a bimodal
distribution (K–S test, P = 1.2610214). (C) Significantly reduced cortical
thickness was observed in Cdkl5 knockout compared with WT controls
in female and male mice (X/X, N = 3; -/X, N= 3; -/-, N = 3; X/Y, N = 3; -/Y,
N = 3; mean 6 SEM, *P,0.05, **P,0.01, ***P,0.001).
doi:10.1371/journal.pone.0091613.g004
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conditional, but not Emx1-conditional Cdkl5 knockouts
(Figure 6EF) when compared to control littermates. Only a
trend for reduced locomotion was seen in heterozygous Dlx5/6-
conditional Cdkl5 knockout females (Figure 6CD) consistent with
a dose-dependent effect of Cdkl5 on this phenotype (Figure 2C).
Next, we measured head tracking responses to a continuously
moving visual stimulus in the visual drum test [23]. Hemizygous
male, but not heterozygous female, Emx1-conditional Cdkl5
knockout mice showed a trend (P= 0.07) for decreased head
tracking compared to control littermates (Figure 6H), while
Dlx5/6-conditional knockouts did not show deficits in head
tracking (Figure 6G). Taken toghether these data argue that
the behavioral phenotypes seen in Cdkl5 knockouts can be mapped
to diverse forebrain neuronal populations, with defects in limb
clasping and head tracking associated with glutamatergic neurons
and hypolocomotion associated with GABAergic neurons.
Conclusions
Constitutive Cdkl5 knockout mice recapitulate several core
features of CDKL5 disorder and serve as a useful animal model of
the disorder. In particular, Cdkl5 knockout mice showed hind-limb
clasping, hypoactivity, defective head tracking, and abnormal
EEG responses to convulsants (Figure 2–3), features that may
Figure 5. Defective cellular signalling in Cdkl5 knockout mice. (A) Western blot analysis of whole brain protein extracts from adult female and
male wild-type and Cdkl5mutant mice. Tubulin was included as a loading control. No change was seen in MeCP2 (top panel) and BDNF (lower panel)
levels in mutant Cdkl5 mice compared with wild-type controls (X/X, N = 10; -/X, N = 6; -/-, N = 10; X/Y, N= 5; -/Y, N= 6). (B) Western blot analysis of
hyppocampal protein extracts from P19 female and male wild-type and Cdkl5 mutant mice. Decreased pAKT was observed in Cdkl5 mutant mic4
compared with wild-type controls (X/X, N= 4; -/X, N = 6/8; -/-, N = 6; X/Y, N= 3; -/Y, N= 5. (C) Western blot quantification revealed a significant
decrease in phospho-Akt immunoreactivity protein in mutant Cdkl5 mice compared with wild-type controls (female: WT, N = 10, HET, N = 6, KO,
N = 10; male: WT, N = 5, KO, N= 6; mean 6 SEM) (mean 6 SEM; *P,0.05, **P,0.01). (D) Representative anti-phospho-rpS6 (240/244)
immunohistochemistry in the S1 cortex of adult wild-type and Cdkl5 mutant mice. (E) Representative anti-phospho-rpS6 (235/236)
immunohistochemistry in the S1 cortex of adult wild-type and Cdkl5 mutant mice. A significant reduction of phosphorylation at serine 240/244
(F) and a trend for reduced phosphorylation at serine 235/236 (G) of rpS6 was observed in layer II–III and V of male and female mutant mice
compared to wild-type controls (X/X, N = 4; -/X, N= 6; -/-, N = 3; X/Y, N = 4; -/Y, N = 4; *P,0.05, *P,0.01).
doi:10.1371/journal.pone.0091613.g005
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model the stereotypic hand movements, hypotonia, eye-tracking
abnormalities, and seizures, respectively, reported in the human
condition. Although early-onset seizures are a key feature of
CDKL5 disorder, we failed to detect any spontaneous seizure or
epileptiform activity in mutant mice on two different genetic
backgrounds (Figure 3 and S3). We interpret these findings as an
indication that Cdkl5 impacts on the development of epilepsy in
humans in a manner significantly different from mice. However,
our findings of an altered profile of EEG burst activity following
kainic acid treatment of Cdkl5 knockout and wild-type mice
(Figure 3 and S3), may nevertheless be useful to identify epileptic
mechanisms impacted by Cdkl5 in the human condition.
Figure 6. Behavioral impairments in Cdkl5 conditional knockout mice. (A–B) Percentage of mice showing hind-limb clasping was
significantly increased in heterozygous female and hemizygous male (B) Emx1 (F/X, N = 13; F/X-Emx1::Cre, N= 9; F/Y, N = 12; F/Y-Emx1::Cre, N= 9), but
not (A) Dlx5/6-conditional Cdkl5 knockout mice (F/X, N= 7; F/X-Dlx5/6::Cre, N= 6; F/Y, N= 4; F/Y-Dlx5/6::Cre, N= 13). (C–F) Home cage activity was
significantly decreased in (E) male hemizygous (F/Y, N = 6; F/Y-Dlx5/6::Cre, N = 13), but not (C) female heterozygous (F/X, N= 5; F/X-Dlx5/6::Cre, N= 4)
Dlx5/6-conditional Cdkl5 knockout mice when compared to control littermates. Normal locomotion activity was observed in (D) female and (F) male
Emx1-conditional Cdkl5 knockout mice when compared to control littermates (F/X, N = 12; F/X-Emx1::Cre, N= 6; F/Y, N = 15; F/Y-Emx1::Cre, N= 9). (G–
H) Number of head tracking saccades was decreased in male, but not female Emx1-conditional Cdkl5 knockout mice (F/Y, N = 7; F/Y-Emx1::Cre, N= 6;
F/X, N= 5; F/X-Emx1::Cre, N= 6). No evidence for deficient head tracking was observed in Dlx5/6-conditional Cdkl5 knockout mice (F/Y, N= 5; F/Y-Dlx5/
6::Cre, N= 11; F/X, N= 5; F/X-Dlx5/6::Cre, N= 5; ***P,0.001, **P,0.01, *P,0.05).
doi:10.1371/journal.pone.0091613.g006
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The phenotype of Cdkl5 knockout mice partially overlaps with
that of Mecp2 knockouts. Both mutants showed hind-limb clasping,
hypoactivity, and reduced dendritic branching of cortical neurons.
In addition, cortical neurons in both knockouts showed reduced
phosphorylation of rpS6, a ribosomal regulatory subunit and
modulator of protein translation [36–38], and Akt, a critical
component of neurotrophin signaling [39] and up-stream modu-
lator of rpS6 via mTOR [38]. These findings suggest that
downregulation of the rpS6 pathway may be a common signaling
deficit in CDKL5 disorder and Rett Syndrome and point to
defective translational regulation as a potential core mechanisms
for common pathological features of the disorder. Importantly, no
evidence emerged for altered BDNF expression or function in
Cdkl5 knockout mice (Figure 5A and S6B) suggesting that this
pathways may not play a major role in common features of
CDKL5 disorder and Rett Syndrome.
The non-overlapping intracellular localization of Cdkl5 and
Mecp2 proteins further argues that they act via different signaling
mechanisms to affect common targets. While Mecp2 is nuclear
and associated with heterochromatin [10] (Figure 1C), Cdkl5 is
both cytoplasmic and nuclear, in the latter case being associated
with speckles, granular structures containing splicing proteins [10].
Although Cdkl5 function within nuclear speckles is presently
unknown, downregulation of Cdkl5 has been shown to increase
speckle size in cultured cells [10]. On the other hand, current
evidence suggests that Mecp2 acts as a chromatin-associated
transcriptional repressor to alter cellular gene expression and
modify neuronal function via the secretion of extracellular factors
[40].
Conditional knockout of Cdkl5 in glutamatergic cortical neurons
(with Emx1::Cre) and GABAergic forebrain neurons (with Dlx5/
6::Cre) revealed a double dissociation of behavioral phenotypes
(Figure 6). These findings have several implications. First, they
suggest that behavioral deficits in CDKL5 disorder derive from the
localized absence of the kinase in forebrain neurons. Second, they
suggest that the limb control and eye tracking phenotypes depend
on cortical motor and visual circuit deficits that are separable from
those underlying hypotonia. Whether the later phenotype depends
on deficits in cortical interneuron function or deficits in sub-
cortical circuits cannot be determined at this point, although the
double dissociation observed in Emx1- and Dlx5/6-conditional
mice suggests that non-cortical regions control the hypolocomo-
tion phenotype. Our findings indicate that therapies aimed at re-
expression of CDKL5 in cortical pyramidal neurons may have
success in reversing the most debilitating behavioral phenotypes of
the disorder.
Several of our findings are similar to those recently described for
a constitutive knockout allele of Cdkl5 in male mice [41]. The
hyperlocomotion described in their hemizygous knockout males in
a novel environment is similar to the locomotor behavior we see in
the open field test (Figure S2B), but constrasts with the marked
hypolocomotion we see in a familiar environment (Figure 2D), a
behavior not investigated in their study. The absence of
spontaneous seizures and EEG abnormalities is consistent with
our results, and the deficits reported in auditory-evoked potentials
are complementary to our findings of abnormal visual-evoked
potentials (Figure 2F). Finally, their data showing a decrease
phorphorylation of both Akt and mTOR are consistent with our
findings indicating that Akt and rpS6 are hypofunctional
(Figure 5BC and 5F). Our results extend these findings to
females, the primary carriers of pathological CDKL5 alleles,
expand the pathological phenotypes involved, and map them to
specific cell-types in the brain. In summary, Cdkl5 knockout mice
promise to serve as a useful tool to identify candidate pathological
mechanisms and test therapeutic interventions for CDKL5
disorder. Similarities between Mecp2 and Cdkl5 knockout mice
suggest that core symptoms of the human disorders arise from
overlapping cellular defects, while differences may provide clues to
the unique pathological deficits associated with CDKL5 disorder.
Supporting Information
Figure S1 Generation and validation of Cdkl5 knockout
mice. (A) Genomic organization of the Cdkl5 locus showing
critical exon 4 (ENSMUSE00000346596), the targeting construct,
successfully targeted Cdkl5 locus (genotyping primers indicated by
arrows), FRT-deleted conditional Cdkl5 knockout allele, and Cre-
deleted constitutive Cdkl5 knockout allele used in the present study.
(B) Confirmation of homologous recombinants by long-range
PCR at 59end (top panel) and 39end (bottom panel). PCR products
of positive clones (lane 1 and 2) showed specific signals when
hybridized with 59 and 39 radioactive-labelled DNA probes. No
signal was detected in PCR-negative samples, consistent with them
being non-homologous or unmodified (lane 3 and 4). (C) mRNA
expression of Cdkl5 exons as estimated by Affymetrix microarray
hybridization in wild-type and Cdkl5 knockout brain confirmed
absence of the deleted exon 4 in knockout mice, but normal
expression of remaining exons consistent with an escape from
nonsense-mediated decay. (D) Semi-quantitative PCR on total
brain RNA from female wild-type and Cdkl5 mutant mice with
primers spanning exons confirmed an absence of exon 4, but
normal levels of exons 2, 3, and 5 in mutant mice. (E) Quantitative
real-time PCR on total brain RNA from female wild-type and
Cdkl5 knockout mice revealed normal levels of expression of
upstream (exon 2–3) and downstream (exon 9–10) Cdkl5 exons. (F)
Anti-Cdkl5 and SC35 immunofluorescence analysis of S1 cortex
brain sections from adult male knockout (KO) mice. (Scale bar
10 mm).
(TIF)
Figure S2 Normal body and brain weight and novelty-
induced locomotion in Cdkl5 knockout mice. (A) No
difference was observed in body weight of female and male wild-
type and Cdkl5 mutant mice (6 weeks old). (B) No difference was
detected in total distance travelled in a novel open arena by adult
female and male wild-type and Cdkl5 mutant mice (female: WT,
N=10, HET, N=9, KO, N=10; male: WT, N=10, KO,
N=11). (C) Representative images of dissected brains from female
wild-type, heterozygous, and homozygous Cdkl5 knockout mice.
(D) No difference in relative brain to body weight was detected
between genotypes (WT, N=6, HET, N=8, KO, N=7; mean 6
SEM). (E) Normal viability was observed of female and male wild-
type and Cdkl5 mutant mice (at 6 months of life) (female: WT,
N=48/50, HET, N=24/27, KO, N=17/20; male: WT,
N=34/39, KO, N=51/54, mean 6 SEM).
(TIF)
Figure S3 Seizure response in Cdkl5 knockout mice
backcrossed to DBA genetic background. Representative
electroencephalogram (EEG) traces recorded from surface elec-
trodes placed over the somatosensory cortex in freely moving male
(A) wild-type (WT) and (B) Cdkl5 knockout (KO) mice following 3
generations backcrossing to the DBA2/J strain. Power spectra of
EEG recordings showed decreased power in Cdkl5 knockouts when
compared to wild-type littermates at low frequencies both under
(C) baseline conditions and (D) in mice injected with kainic acid
(25 mg/kg, i.p.; mean 6 SEM; WT: N=3, KO: N=3).
(TIF)
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Figure S4 Reduced thickness of cortical and hippocam-
pal layers in Cdkl5 knockout mice. (A) Representative image
showing region of S1 cortex used for quantification of cortical
thickness in wild-type and Cdkl5 mutant mice. (B) Representative
image showing features used for quantification of hippocampal
layer thickness in wild-type and Cdkl5 mutant mice. (C–F) A
significant decrease in thickness was observed in hippocampal
CA1 stratum oriens (but not stratum laconosum or radiatum) and the
lower and upper blades of dentate gyrus molecular layer in female
and male Cdkl5 mutant mice compared to wild-type littermates
(female: WT, N=3, HET, N=3, KO, N=3; male: WT, N=3,
KO, N=3; N= 9–13 sections for each genotype) (mean 6 SEM;
*P,0.05, **P,0.01). (G,H) Representative images of reconstruct-
ed neurons from adult male wild-type (WT, G) and Cdkl5 knockout
(KO, H) mice. (I) Total dendrite length was significantly reduced
in male Cdkl5 knockout mice (X/Y, N=15; -/Y, N= 15, mean 6
SEM, *P,0.05, **P,0.01, ***P,0.001).
(TIF)
Figure S5 Reduced dendrite complexity in Cdkl5 knock-
out mice. Classical Sholl analysis with radii increasing in 20 mm
increments. Sholl analysis measures apical dendrite length within
each sphere plotted against radius from soma. Significant
decreases in the numbers of intersections between the dendrites
and the Sholl circles from the neuronal somata occurred only
between 100 mm and 130 mm in cortical neurons (A) and between
80 mm and 120 mm and 140 mm and 160 mm in hyppocampal
dendrite (B) in mutant Cdkl5male mice (Figure S5; P,0.05, Tukey
test).
(TIF)
Figure S6 No change observed in Mecp2 and BDNF
levels in Cdkl5 knockout mice. Quantification of western blot
data failed to detect a change in immunostaining against (A)
Mecp2, and (B) BDNF protein in mutant Cdkl5 mice compared
with wild-type controls (female: WT, N=10, HET, N=6, KO,
N=10; male: WT, N=5, KO, N=6; mean 6 SEM) (mean 6
SEM; *P,0.05, **P,0.01).
(TIF)
Figure S7 Reduced p-rpS6 protein in Cdkl5 knockout
mice. Representative micrographs showing the immunohisto-
chemistry for total rpS6 (A) in the S1 cortex of both female and
male wild-type and Cdkl5 mutant mice. Quantitation of immuno-
reactivity signals revealed no change in total rpS6 protein (B) in
both male and female mutants, a significant decrease of phospho-
rpS6 (240/244) in (C) female and (D) male mutants, and a
decrease of phospho-rpS6(235/236) that was only significant in
layer V of (E) female mutants, while it shows only a trend in (F)
male KOs (female: WT, N=4, HET, N=6, KO, N=3; male:
WT, N=4, KO, N=4; mean 6 SEM; *P,0.05, **P,0.01,
***P,0.001).
(TIF)
Figure S8 Normal body and brain weight (A) No difference
was observed in body weight of heterozygous female and
hemizygous male (A) Dlx5/6- (F/X, N=8; F/X-Dlx5/6::Cre,
N= 7; F/Y, N=5; F/Y-Dlx5/6::Cre, N= 11) and (B) Emx1 (F/X,
N=12; F/X-Emx1::Cre, N= 8; F/Y, N=12; F/Y-Emx1::Cre,
N= 10) conditional Cdkl5 knockout mice at 8 weeks of life. Normal
viability was observed at 6 months of life of heterozygous female
and hemizygous male (C) Dlx5/6- (F/X, N=9/10; F/X-Dlx5/
6::Cre, N= 6/6; F/Y, N=5/5; F/Y-Dlx5/6::Cre, N= 9/10) and
(D) Emx1 (F/X, N=9/11; F/X-Emx1::Cre, N=5/6; F/Y,
N=11/12; F/Y-Emx1::Cre, N=9/9) conditional Cdkl5 knockout.
(TIF)
Acknowledgments
We thank the staff members of the EMBL Phenotyping, Gene Expression,
Transgenic, Monoclonal Antibody, Protein Expression & Purification, and
Genomics Core Facilities. We thank Jeanette Rientjes for expert
recombineering, Rosa Chiara Paolicelli for help in image reconstruction,
Rita Santos for bioinformatics expertise, Mumna Al-Banchaabouchi for
phenotyping expertise, Francesca Zonfrillo for mouse husbandry, and Joe
Ekker and John Rubenstein for the Dlx5/6::Cre mouse strain. This project
was inspired by Emmanuela DeFranceschi and Elena Grella whom we
thank for their ongoing support.
Author Contributions
Conceived and designed the experiments: EA CG. Performed the
experiments: EA YZ CM E. Calcagno E. Castroflorio CF GL DS DF.
Analyzed the data: EA YZ CM E. Calcagno E. Ciani CF GL DS DF.
Contributed reagents/materials/analysis tools: CG E. Ciani TP MG ALV.
Wrote the manuscript: EA CG. Contribution in conception, hypotheses
delineation, and design of the study: E. Ciani TP MG. Involved in paper
revision prior to submission: E. Ciani TP MG.
References
1. Grosso S, Brogna A, Bazzotti S, Renieri A, Morgese G, et al. (2007) Seizures and
electroencephalographic findings in CDKL5 mutations: case report and review.
Brain Dev 29(4): 239–242.
2. Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: from clinic to
neurobiology. Neuron 56: 422–437.
3. Fehr S, Wilson M, Downs J, Williams S, Murgia A, et al. (2013) The CDKL5
disorder is an independent clinical entity associated with early-onset encepha-
lopathy. Eur J Hum Genet 21(3): 266–273.
4. Bahi-Buisson N, Nectoux J, Rosas-Vargas H, Milh M, Boddaert N, et al. (2008)
Key clinical features to identify girls with CDKL5 mutations. Brain 131: 2647–
2661.
5. Evans JC, Archer HL, Colley JP, Ravn K, Nielsen JB, et al. (2005) Early onset
seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum
Genet 13: 1113–1120.
6. Russo S, Marchi M, Cogliati F, Bonati MT, Pintaudi M, et al. (2009) Novel
mutations in the CDKL5 gene, predicted effects and associated phenotypes.
Neurogenetics 10(3): 241–250.
7. Lin C, Franco B, Rosner MR (2005) CDKL5/Stk9 kinase inactivation is
associated with neuronal developmental disorders. Hum Mol Genet 24: 3775–
3786.
8. Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, et al. (2005) CDKL5
belongs to the same molecular pathway of MeCP2 and it is responsible for the
early-onset seizure variant of Rett syndrome. Hum Mol Genet 14: 1935–1946.
9. Rusconi L, Salvatoni L, Giudici L, Bertani I, Kilstrup-Nielsen C, et al. (2008)
CDKL5 expression is modulated during neuronal development and its
subcellular distribution is tightly regulated by the C terminal tail. J Biol Chem
283 (44): 30101–30111.
10. Ricciardi S, Kilstrup-Nielsen C, Bienvenu T, Jacquette A, Landsberger N, et al.
(2009) CDKL5 influences RNA splicing activity by its association to the nuclear
speckle molecular machinery. Hum Mol Genet 18(23): 4590–4602.
11. Chen Q, Zhu YC, Yu J, Miao S, Zheng J, et al. (2010) CDKL5, a Protein
Associated with Rett Syndrome, Regulates Neuronal Morphogenesis via Rac1
Signaling. J Neurosci 30(38):12777–12786.
12. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG
binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat
Genet 27(3): 327–331.
13. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null
mutation causes neurological symptoms that mimic Rett syndrome. Nature
Genetic 27(3): 322–326.
14. Pelka GJ, Watson CM, Radziewic T, Hayward M, Lahooti H, et al. (2006)
Mecp2 deficiency is associated with learning and cognitive deficits and altered
gene activity in the hippocampal region of mice. Brain 129: 887–898.
15. Armstrong DD, Dunn JK, Schultz RJ, Herbert DA, Glaze DG, et al. (1999)
Organ growth in Rett syndrome: a postmortem examination analysis. Pediatr
Neurol 20:125–129.
16. Farley FW, Soriano P, Steffen LS, Dymecki SM (2000) Widespread
Recombinase Expression Using FLPeR (Flipper) Mice. Genesis 28: 106–110.
17. Tang SH, Silva FJ, Tsark WM, Mann JR (2002) A Cre/loxP-deleter transgenic
line in mouse strain 129S1/SvImJ. Genesis 32(3): 199–202.
A Mouse Model of CDKL5 Disorder
PLOS ONE | www.plosone.org 11 May 2014 | Volume 9 | Issue 5 | e91613
18. Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, et al. (2011) Reduced
AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome
animal model. Hum Mol Genet 20(6): 1182–1196.
19. Brankack J, Kukushka VI, Vyssotski AL, Draguhn A (2010) EEG gamma
frequency and sleep-wake scoring in mice: Comparing two types of supervised
classifiers. Brain Res 1322: 59–71.
20. Pizzorusso T, Berardi N, Rossi FM, Viegi A, Venstrom C, et al. (1999) TrkA
activation in the rat visual cortex prevents the effect of monocular deprivation.
Eur J Neurosci 11: 204–212.
21. De Masi F, Chiarella P, Wilhelm H, Massimi M, Bullard B, et al. (2005) High
throughput production of mouse monoclonal antibodies using antigen micro-
arrays. Proteomics 5(16): 4070–81.
22. Rogers DC, Fisher EMC, Brown SDM, Peters J, Hunter AJ, et al. (1999)
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed
protocol for comprehensive phenotype assessment. Mammalian Genome 8:
711–713.
23. Thaung C, Arnold K, Jackson IJ, Coffey PJ (2002) Presence of visual head
tracking differentiates normal sighted from retinal degenerate mice. Neurosci
Lett 325 (1): 21–24.
24. Pizzorusso T, Fagiolini M, Porciatti V, Maffei L (1997) Temporal aspects of
contrast visual evoked potentials in the pigmented rat: effect of dark rearing.
Vision Res 37(4): 389–395.
25. Schauwecker PE (2011) The relevance of individual genetic background and its
role in animal models of epilepsy. Epilepsy Research 97: 1–11.
26. Belichenko NP, Belichenko PV, Li HH, Mobley WC, Francke U (2008)
Comparative study of brain morphology in Mecp2 mutant mouse models of Rett
syndrome. J Comp Neurol 508(1): 184–195.
27. Belichenko NP, Belichenko PV, Mobley WC (2009) Evidence for both neuronal
cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2
in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol Dis 34(1):
71–77.
28. Kishi N, Macklis JD (2005) Dissecting MECP2 function in the central nervous
system. J Child Neurol 20: 753–759.
29. Stuss DP, Boyd JD, Levin DB, Delaney KR (2012) MeCP2 mutation results in
compartment-specific reductions in dendritic branching and spine density in
layer 5 motor cortical neurons of YFP-H mice. PLoS One 7(3).
30. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, et al. (2000)
Imaging neuronal subsets in transgenic mice expressing multiple spectral
variants of GFP. Neuron 28: 41–51.
31. Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, et al. (2006) Brain-specific
phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription,
dendritic growth, and spine maturation. Neuron 52: 255–269.
32. Chang Q, Khare G, Dani V, Nelson S, Jaenisch R (2010) The disease
progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Neuron 49: 341–348.
33. Lonetti G, Angelucci A, Morando L, Boggio EM, Giustetto M, et al. (2010)
Early environmental enrichment moderates the behavioral and synaptic
phenotype of MeCP2 null mice. Biol Psychiatry 67(7): 657–665.
34. Zarbalis K, May SR, Shen Y, Ekker M, Rubenstein JL, et al. (2004) A focused
and efficient genetic screening strategy in the mouse: identification of mutations
that disrupt cortical development. PLoS Biol 2(8): E219.
35. Iwasato T, Nomura R, Ando R, Ikeda T, Tanaka M, et al. (2004) Dorsal
telencephalon-specific expression of Cre recombinase in PAC transgenic mice.
Genesis 38(3): 130–138.
36. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, et al. (2004) S6K1(2/2)/
S6K2(2/2) mice exhibit perinatal lethality and rapamycin-sensitive 59-terminal
oligopyrimidine mRNA translation and reveal a mitogen-activated protein
kinase-dependent S6 kinase pathway. Mol Cell Biol 243: 112–124.
37. Ruvinsky I, Meyuhas O (2006) Ribosomal protein S6 phosphorylation: from
protein synthesis to cell size. Trends Biochem Sci 31: 342–348.
38. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, et al. (2007) RAS/ERK
signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK
and stimulates cap-dependent translation. J Biol Chem 282: 14056–1464.
39. Kaplan DR, Miller FD (2000) Neurotrophin signal transduction in the nervous
system. Curr Opin Neurobiol 10 (3): 381–391.
40. Guy J, Cheval H, Selfridge J, Bird A (2011) The role of MeCP2 in the brain.
Annu Rev Cell Dev Biol 27: 631–652.
41. Wang IT, Allen M, Goffin D, Zhu X, Fairless AH, et al. (2012) Loss of CDKL5
disrupts kinome profile and event-related potentials leading to autistic-like
phenotypes in mice. Proc Natl Acad Sci USA 109(52): 21516–21521.
A Mouse Model of CDKL5 Disorder
PLOS ONE | www.plosone.org 12 May 2014 | Volume 9 | Issue 5 | e91613
